Literature DB >> 11923033

The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.

Patricia J M Best1, Ryan Lennon, Henry H Ting, Malcolm R Bell, Charanjit S Rihal, David R Holmes, Peter B Berger.   

Abstract

OBJECTIVES: We sought to determine the effect of varying degrees of renal insufficiency on death and cardiac events during and after a percutaneous coronary intervention (PCI).
BACKGROUND: Patients with end-stage renal disease have a high mortality from coronary artery disease. Little is known about the impact of mild and moderate renal insufficiency on clinical outcomes after PCI.
METHODS: Cardiac mortality and all-cause mortality were determined for 5,327 patients undergoing PCI from January 1, 1994, to August 31, 1999, at the Mayo Clinic, based on the estimated creatinine clearance or whether the patient was on dialysis.
RESULTS: In-hospital mortality was significantly associated with renal insufficiency (p = 0.001). Even after successful PCI, one-year mortality was 1.5% when the creatinine clearance was > or =70 ml/min (n = 2,558), 3.6% when it was 50 to 69 ml/min (n = 1,458), 7.8% when it was 30 to 49 ml/min (n = 828) and 18.3% when it was < 30 ml/min (n = 141). The 18.3% mortality rate for the group with < 30 ml/min creatinine clearance was similar to the 19.9% mortality rate in patients on dialysis (n = 46). The mortality risk was largely independent of all other factors.
CONCLUSIONS: Renal insufficiency is a strong predictor of death and subsequent cardiac events in a dose-dependent fashion during and after PCI. Patients with renal insufficiency have more baseline cardiovascular risk factors, but renal insufficiency is associated with an increased risk of death and other adverse cardiovascular events, independent of all other measured variables.

Entities:  

Mesh:

Year:  2002        PMID: 11923033     DOI: 10.1016/s0735-1097(02)01745-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  129 in total

1.  Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.

Authors:  Simon Correa; Marc P Bonaca; Benjamin M Scirica; Sabina A Murphy; Erica L Goodrich; David A Morrow; Michelle L O'Donoghue
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

2.  Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention.

Authors:  Elias B Hanna; Anita Y Chen; Matthew T Roe; Stephen D Wiviott; Caroline S Fox; Jorge F Saucedo
Journal:  JACC Cardiovasc Interv       Date:  2011-09       Impact factor: 11.195

3.  Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention.

Authors:  Patrik Htun; Suzanne Fateh-Moghadam; Christian Bischofs; Winston Banya; Karin Müller; Boris Bigalke; Konstantinos Stellos; Andreas E May; Marcus Flather; Meinrad Gawaz; Tobias Geisler
Journal:  J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 10.121

Review 4.  Renal dysfunction and acceleration of coronary disease.

Authors:  M W Yerkey; S J Kernis; B A Franklin; K R Sandberg; P A McCullough
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

5.  Utility of the HAS-BLED score for risk stratification of patients with acute coronary syndrome.

Authors:  Diego Castini; Simone Persampieri; Ludovico Sabatelli; Massimo Erba; Giulia Ferrante; Federica Valli; Marco Centola; Stefano Carugo
Journal:  Heart Vessels       Date:  2019-04-10       Impact factor: 2.037

6.  Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Int Urol Nephrol       Date:  2011-10-16       Impact factor: 2.370

7.  Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis.

Authors:  Lygeri P Soubassi; Theodore C Chiras; Emmanuel D Papadakis; George D Poulos; Dimitrios I Chaniotis; Ioannis P Tsapakidis; Sofia P Soubassi; Stylianos N Zerefos; Nikolaos S Zerefos; Dimitrios A Valis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

8.  The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction.

Authors:  Hans-Peter Hobbach; C Michael Gibson; Robert P Giugliano; Julia Hundertmark; Christel Schaeffer; Wassillij Tscherleniak; Peter Schuster
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

9.  Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.

Authors:  Gjin Ndrepepa; Franz-Josef Neumann; Salvatore Cassese; Massimiliano Fusaro; Ilka Ott; Stefanie Schulz; Petra Hoppmann; Gert Richardt; Karl-Ludwig Laugwitz; Heribert Schunkert; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2013-10-04       Impact factor: 5.460

10.  Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention.

Authors:  C Mueller; F-J Neumann; A P Perruchoud; H J Buettner
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.